Industries > Pharma > Global Cardiovascular Devices Market Forecast 2017-2027

Global Cardiovascular Devices Market Forecast 2017-2027

Diagnostics & Monitoring, Surgical, ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Ultrasound, Echocardiograms, Doppler Foetal Monitors, CT-Scan, PET/SPECT, Cardiac CT MRI, Stents, Valves, Pacemakers, Occlusion Devices, Cannulae, Electrosurgical Devices, Accessories/Consumables, Guidewires, Catheters

PUBLISHED: 16 December 2016
PAGES: 142
PRODUCT CODE: PHA0159
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0159 Categories: , Tags: , ,

The global cardiovascular devices market was valued at $40.05bn in 2016. Visiongain estimates that this market will grow at a CAGR of 6.4% in the first half of the forecast period and reach $54.22bn in 2021.This market is estimated to grow faster in the second half of the forecast period, growing at a CAGR of 7.1% and reach $81.38bn in 2027. The global cardiovascular devices market is estimated to grow at a CAGR of 6.7% from 2017 to 2027.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new report you find 142 page report you will receive 130 charts (tables and figures) – all unavailable elsewhere.

The 142 page report provides clear detailed insight into the global cardiovascular devices market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Global Cardiovascular Devices Market Forecast 2017-2027

Report Scope

Global Cardiovascular Devices Market forecast 2017-2027

Global Cardiovascular Devices National Market forecast 2017-2027, covering:
– US
– Canada
– Germany
– UK
– France
– Spain
– Italy
– Japan
– China
– India
– Brazil
– Mexico
– Rest of the World

Individual revenue forecasts 2017-2027 by application and by devices:
• Global Diagnostics and Monitoring Devices Market:
– Electrocardiogram (ECG/EKG)
– Holter Monitors
– Event Monitors
– Implantable Loop Recorders
– Ultrasound (ECG and Doppler Foetal Monitor)
– Computed Tomography (CT-Scan) (PET/SPECT and Cardiac CT)
– Magnetic Resonance Imaging (MRI)

• Global Surgical Devices Market:
– Stents
– Valves
– Pacemakers
– Occlusion Devices
– Cannulae
– Electrosurgical Devices
– Accessories/Consumables (Guidewires and Catheters)

Analysis of the key factors driving and restraining the growth of the cardiovascular devices market for the period 2017-2027.

Assessment of selected leading companies, examining recent performance and outlooks:
• St. Jude Medical, Inc.,
• Abbott Laboratories
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cook Medical
• Terumo Corporation
• Medtronic plc
• B. Braun Melsungen AG.

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Cardiovascular Devices Market and leading companies. You find data, trends and predictions.

Buy our report today Global Cardiovascular Devices Market Forecast 2017-2027: Diagnostics & Monitoring, Surgical, ECG, Holter Monitors, Event Monitors, Implantable Loop Recorders, Ultrasound, Echocardiograms, Doppler Foetal Monitors, CT-Scan, PET/SPECT, Cardiac CT MRI, Stents, Valves, Pacemakers, Occlusion Devices, Cannulae, Electrosurgical Devices, Accessories/Consumables, Guidewires, Catheters.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Cardiovascular Devices Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Cardiovascular Devices Market Forecast 2017-2027


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category